LB Pharmaceuticals Quarterly Income Statement
NASDAQ: LBRXHealthcareBiotechnologyUSD
37.22+2.61 (+7.54%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LB Pharmaceuticals revenue and earnings
LB Pharmaceuticals reported a net loss of $51.6 million, compared with a loss of $4.9 million a year earlier. Diluted earnings per share came in at -$1.71.
Summary generated from market data by MetaCap's automated system. Methodology
LB Pharmaceuticals income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Expenses | 53.91M | 22.10M | 13.87M | 5.25M | 4.86M | 6.43M | 5.54M | 16.08M | — | — |
| Research & Development | 44.15M | 14.64M | 8.48M | 2.42M | 2.42M | 3.42M | 376.00K | 10.66M | — | — |
| Other Income (Expense) | 2.31M | 3.05M | 2.40M | 1.69M | -12.00K | 1.12M | 469.00K | 1.90M | — | — |
| Pretax Income | -51.60M | -19.05M | -11.47M | -3.56M | -4.87M | -5.31M | -5.07M | -14.18M | — | — |
| Income Tax | 0 | 0 | 1.00K | 0 | 0 | 0 | 1.00K | 0 | — | — |
| Net Income | -51.60M | -19.05M | -11.47M | -3.56M | -4.87M | -5.31M | -5.07M | -14.18M | -27.63M | -16.22M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -1.71 | -0.67 | 25.85 | -0.61 | -13.58 | -14.79 | — | -39.49 | — | — |
| EPS (Diluted) | -1.71 | -0.67 | 25.85 | -0.61 | -13.58 | -14.79 | — | -39.49 | — | — |
| Shares Outstanding (Basic) | 30.14M | 28.24M | — | 5.81M | 358.81K | 358.78K | — | 359.08K | — | — |
| Shares Outstanding (Diluted) | 30.14M | 28.24M | — | 5.81M | 358.81K | 358.78K | — | 359.08K | — | — |
This table shows 10 quarterly periods of LB Pharmaceuticals's income statement, from Q2 2026 back to Q1 2024, across 10 line items including operating expenses, research & development, other income (expense). Values in USD; B = billions, M = millions. Fiscal periods follow LBRX's reporting calendar. What is a income statement?